10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
Rhea-AI Summary
10x Genomics (Nasdaq: TXG) will report its second quarter 2026 financial results for the period ended June 30, 2026 after market close on Thursday, August 6, 2026. The company will host a public conference call and live webcast at 1:30 p.m. PT / 4:30 p.m. ET to discuss results, business developments and outlook, with materials and the news release available on the investor section of its website and a webcast replay accessible for at least 45 days.
Positive
- None.
Negative
- None.
News Market Reaction – TXG
In the Jul 16 session, TXG declined 2.78%, reflecting a moderate negative market reaction. Argus tracked a trough of -3.9% from its starting point during tracking. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 15 | Earnings date notice | Negative | -0.4% | Company scheduled Q1 2026 earnings release and investor conference call date. |
| Jan 22 | Earnings date notice | Negative | -3.5% | Company announced Q4 and full-year 2025 earnings release timing and webcast details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
TXG shares have generally drifted lower following past earnings date announcements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (https://www.10xgenomics.com/), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-second-quarter-2026-financial-results-on-august-6-2026-302826655.html
SOURCE 10x Genomics, Inc.